Session 6, Presentation 3, The crucial role of the GLG on AMR to support antibacterial innovation
14 March 2023
| Standards
Overview
The sixth meeting of the GLG, Session 6 'The crucial role of the GLG on AMR to support antibacterial innovation' presentation.
Kevin Outterson, Executive Director and Principal Investigator, CARB-X, presented an overview of the pre-clinical pipeline for new antimicrobials and alternatives.
WHO Team
One Health Global Leaders Group on Antimicrobial Resistance